Podcasts about ozempic

February is Eating Disorder Awareness Month. And if you're stuck in quasi-recovery, telling yourself "I'm fine," avoiding help because you're ashamed—this is your wake-up call. I'm sharing 2026 statistics you haven't heard, alarming trends getting WORSE, and the truth about Ozempic, social media, and eating disorders. Because sis, you are not a statistic. At least not a negative one. But you need to hear this. What you'll learn: Why eating disorders increased 15% since 2020 (28.8 million Americans affected) The shocking truth: Every 52 minutes someone dies, only 10% get treatment Midlife crisis: 42% increase in hospitalizations for women 45-65 Ozempic danger: 300% prescription increase, 40% of users have ED histories, 45% relapse when stopping Social media impact: 3+ hours/day = 60% higher ED risk Post-pandemic fallout: 25-30% global increase still climbing My story: When I refused to be a negative statistic 3-question self-assessment to know if you need help NOW The wake-up call: Every day you wait, you're missing out on life. KEY STATISTICS

#939: Join us as we sit down with Dr. Gerry Curatola – internationally acclaimed biologic dentist, bestselling author, pioneering researcher, & humanitarian with more than 40 years of clinical experience. In this episode, Dr. Gerry breaks down why your oral microbiome is the gateway to total-body health, exposes the truth about fluoride, unpacks the hidden dental risks of Ozempic & GLP-1s, reveals what jaw clenching says about your stress levels, & explains the powerful connection between your mouth, the vagus nerve, & your nervous system.   To watch our last episode with Dr. Gerry Curatola visit https://youtu.be/N98YCKp8nWQ?si=ytVIO3f2n9-LykHs   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with Dr. Gerry Cuatola click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Head to our ShopMy page HERE and LTK page HERE to find all of the products mentioned in each episode.   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   To Shop Revitin go to https://tidd.ly/4tiPLZq and use code SKINNY for 15% off.    To book a virtual consultation go to http://rejuv-health.com and use code SKINNY for 20% for a limited time.    This episode is sponsored by The Skinny Confidential The beauty tool that started it all, redesigned to evolve with you. Shop Ice Roller at https://bit.ly/IceRollerSilver today.   This episode is sponsored by Minnow Shop minnow's new apré-ski capsule collection at http://shopminnow.com and enter code MEETMINNOW15 at checkout to receive 15% off your first order.    This episode is sponsored by American Beverage Association Visit http://www.goodtoknowfacts.org/ for more information.   This episode is sponsored by Ollie Treat your Palentine with Ollie! Go to http://ollie.com/skinny and use code skinny to get 60% off your first box!   This episode is sponsored by Puori Use code SKINNY at http://puori.com/SKINNY to get 32% off Puori Grass-fed Whey Protein when you start a subscription.   This episode is sponsored by Experian Get started in the Experian App now!   This episode is sponsored by WOO More Play Visit https://woomoreplay.com to learn more about WOO More Play and get 20% off site wide. Produced by Dear Media

On Food Talk with Dani Nierenberg, Dani speaks with Ndidi Okonkwo Nwuneli, the President and CEO of the ONE Campaign. They discuss how the dismantling of the U.S. Agency for International Development has impacted the African continent, the opportunities this shifting landscape creates for the emergence of African-led solutions, and the innovative women spearheading food and agriculture systems transformation. Plus, hear about the recent extension of the African Growth and Opportunity Act, severe storm damage in Portugal and Spain causing hundreds of millions of euros in agricultural losses, new recommendations from the World Resources Institute for retailers to help reduce household food waste, and a looming strike at the JBS meatpacking plant in Colorado over alleged inhumane working conditions. Dani also discusses GLP-1 drugs like Ozempic and Wegovy, noting their complex and under-researched impact on people with eating disorders, including both potential benefits and serious risks. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to "Food Talk with Dani Nierenberg" wherever you consume your podcasts.

Injectable peptide therapy, a controversial wellness trend that caught fire online in 2025, shows no signs of slowing down in 2026 despite an overwhelming lack of safety data. Peptides, especially “research peptides” like BPC-157 and TB-500, have been hailed by famous podcasters, biohackers, and longevity gurus as a miracle cure for just about anything that ails you, from torn ligaments and gut issues to curbing wrinkles and dull skin. There are several well-studied, FDA-approved peptides available today, such as insulin and GLP-1s like Ozempic and Wegovy, but that's just a sliver of the peptide pie. There are thousands more with glowing online reviews, but scant scientific data, that can be procured online or through longevity clinics. Mixes of various peptides, called “peptide stacks,” often come with clever names like the ‘'wolverine stack' or ‘glow protocol', while others have earned names like ‘Barbie peptide' for their ability to tan the skin without the sun. These popular stacks are not FDA-approved, so they're distributed online as 'research peptides' that are meant for in-lab research, not human use — a workaround for their gray market status. To find out more, host Lexy Lebsack sat down with two experts on the topic. First up was NYT's David Dodge (8:42), who walked us through the rise of peptide therapy online. He published an article for NYT in November titled “The internet loves peptide therapy. Is it really a miracle cure?” Lebsack also interviews McGill's Jonathan Jarry (29:35), who wrote an article in late 2023 — well ahead of a rush of online articles — called “The human lab rats injecting themselves with peptides.” Jarry walks us through the hard science, and lack thereof, of many popular stacks, ahead.

Ming Thein, co-founder of the boundary-pushing Ming Watches, is always full of surprises, and this conversation, recorded at Dubai Watch Week, is no exception. We talk about the incredible titanium Polymesh bracelet, how Ming is adapting to being part of the 'old guard' of indies, and how to overcome imposter syndrome.  On top of that, we get some cryptic clues as to what 2026 might have in store. But before that, Felix and Andy debrief on the latest releases from Audemars Piguet, and Andy explores the concept of the 'Ozempic' wrist.  All the latest from Audemars Piguet (1:26) A. Lange & Söhne's new Sydney boutique (7:48) Ozempic wrist, explained (9:55) Ming Thein interview (12:51) Show Notes: https://www.otpodcast.com.au/show-notes OT: Discord - https://discord.com/invite/X3Vvc9z7aV How to follow us: https://www.instagram.com/ot.podcast https://www.facebook.com/otpodcastau https://instagram.com/andygreenlive https://instagram.com/fkscholz Send us an email: otthepodcast@gmail.com If you liked our podcast, please remember to like/share and subscribe.

Ibai Llanos ha perdido peso y, a pesar de explicar públicamente que no ha utilizado fármacos tipo GLP-1, parte de las redes sociales ha cuestionado su proceso. La sospecha ha sido automática: “Seguro que ha usado Ozempic”. En este episodio reflexionamos sobre algo mucho más profundo que un caso concreto. ¿Hemos normalizado tanto la medicación para perder peso que ya no creemos en el cambio de hábitos? ¿Estamos medicalizando el cuerpo y patologizando el hambre? ¿Qué dice de nosotros que nos resulte más creíble una inyección que un proceso sostenido en el tiempo?Hablamos de qué son realmente los análogos de GLP-1, cuándo están indicados, qué implicaciones tienen y por qué el debate no debería centrarse en señalar a una persona, sino en analizar la narrativa colectiva que estamos construyendo alrededor del peso, la salud y la cultura de la delgadez.Un episodio para pensar más allá del titular.Conviértete en un supporter de este podcast: https://www.spreaker.com/podcast/comiendo-con-maria-nutricion--2497272/support.

Hi everyone, I'm Dr. Liza Leal, your host today for the Meridian Medical Dental Healthcare Podcast, powered by Meridian Health Institute — and I'm also known as your Everyday Health Hacker.Today we're talking about what's really happening to your collagen, muscle, and hormones when you're on GLP-1 medications — and more importantly, what you can do to stay looking healthy, strong, and vibrant while you lose weight. A lot of people using GLP medications experience rapid fat loss. While that's wonderful for metabolic health, many people start noticing changes in their skin. Their face can look more hollow or sallow, skin may feel thinner or less elastic, and they may notice sagging in areas like the jawline, neck, arms, or abdomen. So let's talk about how to prevent that.

Jared is joined by original U Up? co-host Sami Sage for a fun episode that kicks off with body image, Ozempic shame, and why vulnerability isn't owed, but it does matter. They unpack a listener's dilemma about dating a woman who may have lost weight on GLP-1s and whether hiding old photos is a red flag, a boundary, or none of his business. Then they review texts from a guy who gives his date the ick by editing his messages multiple times, one edit should be the max! Sami and Jared also discuss what women should actually get men for the upcoming Valentine's Day. Lastly, they dig into two red flag deal breakers: staying close with an ex-wife and being single at 33 – is that a red flag? Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Mike talks about the ways you can improve your physique and body composition with specific training styles. If you want to lose fat and build muscle, this episode will help you understand the most effective strategies for doing so------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

Would you believe that there's a medication that can quiet the constant mental chatter around food for the first time in your adult life, but it could also cause you to lose muscle, age your face, and trap you in a cycle that's hard to escape? Both of those are true. When a drug can help someone lose 50 pounds and get off diabetes medication, that's a miracle. But when that same drug leaves someone unable to eat, losing muscle, and facing a lifetime of injections just to maintain their weight—that's a conversation we truly need to have. So, today we're taking a deep dive into GLP-1s—Ozempic, Wegovy, Mounjaro, and what's coming next. How to preserve muscle when taking GLP-1 medications Consume 1.2–1.6 g of protein per kilogram of body weight daily, spread across meals  Try to eat something containing 25–30 grams of protein within about two hours after doing a strength workout Consume easily digestible protein sources when your appetite is low (shakes, yogurt, collagen, or bone broth) Commit to doing resistance training at least two to three times a week Monitor your body composition for any early signs of muscle loss  Bio: Stephanie Gray Stephanie Gray, DNP, MS, ARNP, AGNP-C, ABAAHP, FAARFM, is a functional medicine provider helping men and women build sustainable, optimal health and longevity. A nurse practitioner since 2009, Dr. Gray completed her doctorate focusing on estrogen metabolism from the University of Iowa in 2011 and holds a Master's in Metabolic Nutritional Medicine from the University of South Florida's Medical School. Dr. Gray is one of the Midwest's most credentialed female healthcare providers. She completed an Advanced Fellowship in Anti-Aging, Regenerative, and Functional Medicine in 2013 and became Iowa's first BioTe certified provider—now the state's only platinum provider with over 10,000 pellet placements. She is also certified as a SIBO doctor-approved practitioner, mold-literate provider, and ReCODE 2.0 practitioner for cognitive decline prevention. An Amazon best-selling author, Dr. Gray wrote Your Longevity Blueprint and Your Fertility Blueprint, and hosts the Your Longevity Blueprint podcast. She co-founded Your Longevity Blueprint Nutraceuticals with her husband, Eric. After her own ten-year fertility journey, she now specializes in helping couples optimize reproductive health through functional medicine. Having lost her grandmother to vascular dementia, she is personally committed to helping families avoid cognitive decline. Dr. Gray founded the Integrative Health and Hormone Clinic in Hiawatha, Iowa. In this episode: How muscle preservation becomes non-negotiable when your appetite is suppressed Why protein timing matters more than total calories when on GLP-1 medications The importance of resistance training when taking GLP-1s The value of in-body scans for catching any muscle loss that may be occurring early on Why tapering off GLP-1 medications starts on day one, not at the finish line How natural GLP-1 stimulation can support or extend the effects of GLP-1 medications Why body composition, not weight loss, determines long-term outcomes when taking GLP-1s How the next generation of GLP-1 agonist drugs could improve our longevity Links and Resources: Relative Links for This Show: Use CODE BERBERINE to get 10% off ⁠⁠⁠Berberine  ⁠⁠⁠⁠⁠⁠Use Code FIBER to get 10% off GLP-1 Fiber Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

GLP-1 medications like Ozempic and Wegovy are everywhere—and so are the opinions. In this episode, Andrew breaks down what GLP-1 actually is (a natural gut hormone), how GLP-1 medications work, and why newer “dual agonist” options like Mounjaro/Zepbound tend to produce bigger weight-loss results. We also tackle the controversy: is obesity a disease, and are GLP-1s “taking the easy way out”?You'll hear a coach's perspective from years in the trenches—why weight loss is effortless for some people and brutally hard for others, what typical results look like, common side effects, why many people stop, and what usually happens when you discontinue the meds.Chapters00:00 — Why GLP-1s are “big” right now01:12 — How common is obesity and GLP-1 use?05:20 — Obesity as a disease09:10 — The blame game12:40 — Are GLP-1's the easy way out?23:16 — GLP 101: what it is and what it does31:30 — Results, side-effects, and plateausThe Co-Movement Gym Podcast is supported by Native Path Supplements and Lombardi Chiropractic.

A WFAN caller backs Craig Carton in the Spring Training debate proving he WASN'T crazy after all but that's just the beginning. What starts as sports talk spirals into a wild conversation about Ozempic taking over the world, Tom Brady's endorsements, AI replacing actors (and maybe athletes), Megan Fox robot movies, and whether baseball could someday be COMPLETELY fake.

Craig Carton and Chris McMonigle take a wild ride from weight-loss trends to sports immortality. A caller proudly talks about being on GLP-1… which sparks a hilarious debate does Ozempic make people BORING?! Then the conversation turns nostalgic and emotional… remembering Mickey Mantle, meeting Joe DiMaggio, and the rare athletes whose deaths were so massive their funerals were televised nationwide. From Mantle to Muhammad Ali… to Kobe Bryant… who today would truly stop the country?

This Day in Legal History: Nelson Mandela ReleasedOn February 11, 1990, Nelson Mandela was released from Victor Verster Prison in South Africa after 27 years of incarceration, marking a seismic shift in the country's legal and political landscape. Mandela's release followed a period of secret negotiations between the apartheid government and the African National Congress (ANC), and it signaled the beginning of the end of apartheid—a system of institutionalized racial segregation and oppression upheld by law. His imprisonment had become a global symbol of the fight against racial injustice and was frequently challenged by international human rights organizations and legal scholars as a violation of fundamental human rights.Mandela had been convicted in 1964 of sabotage and other charges under South Africa's Suppression of Communism Act, following the infamous Rivonia Trial. He was sentenced to life imprisonment, spending much of his sentence on Robben Island under harsh conditions. Over the decades, growing international sanctions and internal unrest made apartheid increasingly untenable.Then-President F.W. de Klerk's government began rolling back apartheid legislation in the late 1980s, and on February 2, 1990, de Klerk announced the unbanning of the ANC and his intention to release Mandela. Just nine days later, Mandela walked free, delivering a speech in Cape Town that emphasized reconciliation, peace, and the continuation of the struggle for full democratic rights.Mandela's release was not just a political milestone—it was a legal one, too. It reflected a move away from laws based on racial supremacy and toward a constitutional order grounded in human rights. This transformation would culminate in South Africa's 1996 Constitution, often lauded for its rights-based framework and independent judiciary.The Trump administration's plan to repeal the EPA's 2009 endangerment finding—the scientific basis for regulating greenhouse gases under the Clean Air Act—could reignite legal efforts to hold polluters accountable through public nuisance lawsuits. That finding enabled the EPA to regulate emissions from vehicles and power plants, but its reversal removes the legal framework that had previously shielded companies from such claims under a 2011 Supreme Court ruling. In that decision, the Court held that the EPA's authority under the Clean Air Act displaced common-law nuisance suits against emitters. Without that EPA oversight, legal scholars believe plaintiffs may now argue that the courts are once again an appropriate venue for these claims.Public nuisance lawsuits, typically filed by states or municipalities, seek to hold companies accountable for harms caused to community health and safety. These cases have been historically difficult to win due to challenges in proving direct causation, but experts say the new regulatory gap could encourage a wave of litigation. Industry groups like the Edison Electric Institute have warned that repealing the endangerment finding could expose utilities to costly legal battles. While federal courts had largely blocked such claims, state courts have shown more openness, and the shift in federal policy may strengthen these legal efforts. Environmental advocates may now have renewed leverage to push power companies and other emitters into court.Trump's repeal of climate rule opens a ‘new front' for litigation | ReutersAttorney General Pam Bondi is scheduled to testify before the House Judiciary Committee this week amid intensifying legal scrutiny over the Justice Department's management of the Jeffrey Epstein files. Lawmakers are expected to question Bondi about what they view as excessive redactions and the DOJ's withholding of key documents, actions that may conflict with a bipartisan federal law passed in 2025 mandating the broad release of Epstein-related materials. Legal analysts suggest the DOJ's reliance on legal privileges—such as investigatory and deliberative process exemptions—to justify redactions could face stiff challenges in court or through congressional oversight powers.The situation raises constitutional tensions between legislative oversight and executive privilege, particularly as the House panel, now under Republican control, examines whether the DOJ is shielding politically sensitive information. Some members of Congress have accused the Department of undermining transparency and potentially violating the statutory intent of the Epstein Disclosure Act, which narrowed the DOJ's discretion in withholding records tied to convicted sex offenders or deceased suspects like Epstein.Bondi's DOJ has been accused of prioritizing partisan enforcement over institutional neutrality, illustrated by failed prosecutions of Trump critics and an aggressive posture on immigration and protest-related cases. The sidelining of the DOJ's civil rights division and the refusal to investigate federal shootings has further fueled concerns over selective enforcement and erosion of prosecutorial independence. Bondi's testimony will serve as a key moment to defend the Department's use of legal redactions and its broader approach to politically charged prosecutions.Bondi to face questions on Epstein files in House testimony | ReutersInstagram chief Adam Mosseri is set to testify in a Los Angeles courtroom this week in a groundbreaking lawsuit that could reshape how U.S. law approaches the intersection of product design and youth mental health. The case centers on a 20-year-old plaintiff who alleges she became addicted to Instagram as a child due to its deliberately addictive interface—particularly the “endless scroll” feature that loads content continuously to hold user attention. Her lawyers argue that Instagram's design choices amount to a form of negligent product engineering that failed to account for known risks to children.This case raises novel legal questions: Can user interface (UI) design be treated as a defective product under tort law? Can tech companies be held liable not just for content but for the architecture of the platforms themselves? If the court accepts these arguments, it could establish precedent for treating addictive design as a public health harm similar to tobacco or opioid marketing practices.Mosseri is expected to face questioning over internal documents that, according to the plaintiff, show Meta was aware of the app's mental health impact on vulnerable teens. Meta counters that these documents reflect efforts to mitigate harm, not evidence of negligence. Still, the case may test the limits of Section 230 immunity, as it focuses not on third-party content, but the platform's own design—potentially sidestepping the traditional legal shield for tech companies.Hundreds of similar cases are pending, and this trial may serve as a bellwether for litigation nationwide. International developments, including Australia's ban on social media for children under 16, suggest this is a growing legal frontier.Instagram's leader to testify in court on app design, youth mental health | ReutersNovo Nordisk's recent patent infringement lawsuit against Hims & Hers marks a pivotal legal development in the pharmaceutical industry's battle with telehealth providers distributing compounded drugs. The suit, filed in Delaware federal court, targets Hims' sales of compounded semaglutide—the active ingredient in Wegovy and Ozempic—claiming these formulations infringe Novo's patents. While compounding is allowed under certain FDA exemptions, those exemptions do not shield pharmacies or telehealth platforms from patent liability. This case challenges the assumption that FDA compliance protects against infringement claims, exposing a gray area where regulatory and intellectual property regimes collide.Historically, brand-name drugmakers focused on trademark challenges over how compounded drugs were marketed. Novo's move into patent litigation signals a strategic escalation: it's not about branding anymore—it's about the act of making and selling the compound itself. Experts highlight that this is likely the first time a brand drug company has pursued patent claims directly against a compounding pharmacy or telehealth distributor, suggesting the industry now sees these entities as substantial commercial threats.The case also underscores a novel enforcement strategy: suing the telehealth platform facilitating sales rather than the dispersed network of compounding pharmacies, streamlining legal action and potentially setting precedent for centralized liability. Hims, already under regulatory scrutiny, had just halted plans to sell compounded semaglutide pills but remains a target due to its involvement in injectable forms.The outcome of this case may clarify how FDA-sanctioned compounding intersects with patent protections and could define the boundaries for how far telehealth companies can go in offering customized versions of patented drugs.Novo's GLP-1 Patent Suit Against Hims Takes Aim at Compounding This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Have you ever quietly wondered if Ozempic or Mounjaro would just make this whole weight thing easier? In this short episode, I explore why weight feels especially hard for women in midlife and what these medications are actually doing beneath the surface. We talk hormones, stress, insulin, and why willpower is rarely the real issue. If you feel stuck despite doing “all the right things,” there is a reason. Want to understand what is really driving your weight? Join my live masterclass, Why Does Weight Feel So Hard for Women? where I break down the root causes and what actually works for sustainable, hormone supportive fat loss. Register here.

We're back and it's midnight in London, 11am in Melbourne. We chat about police paranoia, Ozempic, good advice and more! If you enjoy the podcast and want to support us while gaining access to full length episodes, videos and the WhatsApp communities then head over to www.patreon.com/wearetvi Learn more about your ad choices. Visit megaphone.fm/adchoices

Topics:  Post NFL, Marvel, Prayer, Breaking Animal News, Living Water BONUS CONTENT: Pop-Up Racism, Super Bowl Half-time   Quotes: "God has filled the world with so much mystery, meaning, beauty, and complexity." "The joke has not been made." "There is a Good King who is better than you could ever hope or wish." . . . Holy Ghost Mama Pre-Order! Want more of the Oddcast? Check out our website! Watch our YouTube videos here. Connect with us on Facebook!

Episode 2745 - The care and feeding of dormant iguanas? Is this a cause of colon cancer? Bad Bunny lyrics? Ozempic causing blindness? Plus much more!

GLP-1s like Ozempic and Wegovy are dominating the conversation around weight loss — but what happens when the prescription ends? In this episode, Shana sits down with Lindsay Venn, PA-C, RD, and Clinical Director of Insulin IQ, to unpack how to reverse metabolic dysfunction without relying on lifelong medication. They explore why insulin resistance is the real root issue, how to safely taper off GLP-1s without losing your progress, what labs can reveal your true healing status, and why many chronic diseases — including cancer — are deeply tied to your metabolism. This episode is a must-listen if you're struggling with fatigue, weight, hormonal chaos, or feeling like your body just isn't responding anymore. What We Covered: Why GLP-1s may help but not heal your metabolism The most important labs to run before tapering off Common mistakes when weaning off Ozempic & Wegovy How insulin, mitochondria, and inflammation connect to cancer The role of fasting insulin, meal timing, and light in true healing The #1 lifestyle shift to calm your hormones and burn fat naturally Links & Resources: Learn more about Lindsay: vennintegrativemedicine.com Reverse insulin resistance, fatty liver, and cholesterol issues: https://shanahussinwellness.com/fattyliverguide/ Join my 90-Day Insulin Reset: https://shanahussinwellness.com/programs-courses/reset/ Connect with Shana: Instagram: @shana.hussin.rdn Facebook: Shana Hussin Wellness

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

Lately, the world is heavy. Overwhelming. At times, even unsafe. And I'll be honest, it's been hard to show up and talk about things like body image, weight, or self-care when everything around us feels so serious.But then I watched the Super Bowl halftime show and Bad Bunny showing up boldly, joyfully, unapologetically, and it brought me back to a quote that stopped me in my tracks: joy is part of the resistance.In this episode, I'm sharing a very real moment of burnout. One where I was so overwhelmed I would've rather gone to the emergency room than keep dealing with life, even though nothing was physically wrong. We talk about the kind of society we're living in, where people secretly wish for a stomach virus just to get a break, and what it means when rest only feels allowed through sickness.I share why a glow up has shifted from nice-to-have to need-to-have — focusing first on the inside, not the outside — and how choosing movement, care, joy, and self-respect isn't avoidance, it's survival.If you feel exhausted, overwhelmed, and weighed down by the world around you, this episode is for you.

Gary and Shannon break down the FBI's Guthrie suspect photos and debate whether you'd recognize someone you know behind a ski mask. Then, SwampWatch digs into the Epstein files as Congress threatens to read protected names on the House floor, plus Commerce Secretary Lutnick's Caribbean lunch problem. And the wild turn: Ozempic is giving people an old pirate disease, which somehow leads to Shannon's dad and John Kobylt's nutrient habits. The hour wraps with details on the just-announced GaS 10-year anniversary party.See omnystudio.com/listener for privacy information.

Biological aging doesn't have to match your birth certificate—and that truth could change everything.     In this episode of The Lisa Fischer Said Podcast, Lisa sits down with Dr. Mark Sherwood to unpack how biological age, circadian rhythm, and metabolic health determine how long—and how well—we live. Dr. Sherwood explains why Americans are "living longer but dying slower," how food timing impacts hormones and cortisol, and why eating after sunset may be accelerating aging.     They dive into intermittent fasting, insulin resistance, food noise, GLP-1 medications like Ozempic, and why weight loss alone is the wrong goal. Dr. Sherwood also breaks down biological age testing, peptides, inflammation, muscle loss, and how to extend health-span—not just lifespan. This is a practical, science-backed conversation that challenges conventional wisdom and reframes what "normal aging" really looks like.    

Hour 2 of A&G features... Hour of desperation for the Guthrie family & Charlotte, NC safety hearing The Super Bowl halftime show Trans athlete beats an actual girl... again Chicken Banana & Ozempic causing scurvy See omnystudio.com/listener for privacy information.

Send a textThis week on The Weekly Dose, Dave Knapp breaks down the biggest questions shaking up the GLP-1 world. From whether patients should be stocking up on compounded injectables, to what Eli Lilly's earnings call revealed about Zepbound QuickPens, refill rules, and the long-awaited retatrutide timeline, this episode covers it all. Dave also unpacks FDA enforcement signals, the escalating tension between Big Pharma and compounders, the Hims & Hers controversy, and what recent lawsuits and Super Bowl ads tell us about where obesity treatment is headed next. Clear context, real-world implications, and what patients should be discussing with their doctors right now.Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

Medications that quiet food noise are everywhere right now. They’re being talked about in doctors’ offices, on social media, and in conversations between women who are just desperate for some peace around food. So instead of approaching this topic with judgment, fear, or extremes, let’s have an honest, transparent conversation about what’s really happening in the brain—and what actually leads to lasting change. Ozempic might be quieting the food noise for some women, but what happens when the medication wears off, the weight comes back, or the brain circuits underneath remain untouched? In this episode, Leanne Ellington dives into what she calls the brain-based effect—a natural, sustainable way to quiet the food noise by working WITH your brain’s built-in circuitry for peace, safety, and self-control. This episode isn’t here to judge the medication—or debate whether you should or shouldn’t take it. We’re not here to talk about the pill. We’re here to talk about the pattern. Because no matter how the food noise gets quieted… if you don’t rewire what’s underneath, it’s just a temporary fix. Inside, Leanne breaks down: - The exact brain circuits that drive food obsession—and how emotional eating, cravings, and compulsive thoughts are wired in neurologically (not rooted in a lack of discipline)- Why medications like Ozempic can temporarily turn down the “food noise”… but don’t rewire the deeper brain loops causing it in the first place- How to create a natural effect in your brain by calming your nervous system, retraining your emotional coping patterns, and rewiring the food-seeking circuit—for good This episode blends cutting-edge brain science with Spirit-led truth—and gives you a roadmap to heal your brain, reclaim your peace, and end the war with food once and for all. Because when your brain is rewired for truth… the noise finally goes quiet. HOST: Leanne Ellington // StresslessEating.com // @leanneellington To learn more about Leanne, head over to www.LeanneEllington.com, and to share your thoughts, questions, feedback, or guest suggestions instantly, head on over to www.WhatsGodGotToDoWithIt.com.Follow Leanne on Instagram: https://www.instagram.com/leanneellington/See omnystudio.com/listener for privacy information.

The most impactful development of the past week that's gained the least amount of attention has been the rollout of TrumpRx. The program launched with 43 drugs (including high-profile ones like Ozempic, Wegovy, Zepbound, and fertility treatments) from companies like Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, and others offering Americans the lowest price available on these drugs anywhere in the world. 

Seek has written down its investment in Chinese jobs portal Zhaopin by $365 million after the company’s poor performance. Stellantis, the owner of Jeep and Chrysler, saw its shares plummet 30% after its mega-investment in electric vehicles failed to pay off. The private equity owners of The Man Shake are looking to offload the company after the weight loss market has been totally re-shaped by Ozempic and oc. _ Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.__See omnystudio.com/listener for privacy information.

Zoning Out Podcast presented by The Comedy Zone is back — Jordan Centry, Jonathan Williams (@MrWilliamsComedy), and Jason Allen King kick it off with friendly fit-check chaos (including an Ozempic roast that gets out of hand), then dive into two wild weeks of “what is happening in the world?” energy: unexpected snow/ice stories, teen party memories, and a very questionable “files” conversation that turns into jokes about rich people being way too bold in emails. From there, the episode swerves into music + pop culture: Kendrick Lamar's Grammy run, the Drake discourse, Kanye's apology era (including where he chose to apologize), and a quick detour into Sydney Sweeney rumor territory that immediately proves why you should never trust the first headline you click. Then the boys introduce a new recurring segment: “60 Seconds of Non-Expertise” — rapid-fire, improvised “deep dives” on topics they absolutely should not be trusted to explain (Seahawks vs Patriots, Michelle Williams' film career, Kendrick + Tupac… and yes, someone says “gang community”). They wrap with upcoming shows and big announcements — including Jason opening for Anthony Jeselnik at Goodnights in Raleigh — plus Jordan's Valentine's Day Brunch comedy show, Comics React Live at The Comedy Zone, and a reminder to grab tickets for THREE COMEDY at the Cain Center in Cornelius on Tuesday, March 10.  TICKETS / SHOW INFO • THREE'S COMEDY — Cain Center for the Arts (Cornelius, NC) — Tuesday, March 10 • Jason Allen King opening for Anthony Jeselnik — Goodnights (Raleigh) — Feb 19–21 • Jordan Centry: Valentine's Day Brunch Show — Deluxe Fine Dining (Uptown Charlotte) — Feb 14 • Comics React Live (CRL) — The Comedy Zone — Feb 19  FOLLOW + SUBSCRIBE Subscribe for full episodes + clips, and follow us on IG for show updates.

Hour 2 of A&G features... Hour of desperation for the Guthrie family & Charlotte, NC safety hearing The Super Bowl halftime show Trans athlete beats an actual girl... again Chicken Banana & Ozempic causing scurvy See omnystudio.com/listener for privacy information.

Introduction — Are GLP-1 Drugs Forever?Have you heard experts say that GLP-1 medications like Ozempic, Wegovy, or Zepbound are forever drugs — because once you stop, you regain all the weight?I'm not fully convinced that's true.I've found three promising approaches being developed that may help people stop medication without immediate weight regain.Each approach is completely different:One focuses on the stomachOne on the brainOne on structured lifestyle interventionI'm Dr. Gary Pepper. I've practiced endocrinology for over 30 years. This podcast is unsponsored, and I receive no financial compensation from the treatments discussed. This content is educational only and not a substitute for medical care from your physician.Chapter 1 — Resetting the Gut (DMR)The first approach is called Duodenal Mucosal Resurfacing (DMR).The theory is that while you're on GLP-1 medication, the part of the stomach that normally produces appetite-regulating hormones becomes dormant. After long enough, it may struggle to restart when medication stops.DMR removes the top layer of the stomach lining using a heated endoscope. This forces regeneration of fresh cells that produce appetite-controlling hormones.In a short three-month study, patients who underwent the procedure did not regain weight after stopping medication — some continued to lose.This sounds dramatic, but the technique is already FDA-approved for other stomach conditions. It is not yet approved for weight management, but it shows where research is heading.Chapter 2 — Retraining the Brain (rTMS)The second approach targets the brain instead of the gut.It's called Transcranial Magnetic Stimulation (rTMS) — already used for depression treatment.Magnetic coils stimulate appetite control centers in the brain. After just five weeks of treatment, participants lost as much weight over a year as those taking semaglutide for a full year.This is early research, but it suggests appetite control may eventually be trained neurologically rather than chemically.Chapter 3 — Exercise as Hormone RehabilitationThe third approach is the most practical and immediately available: structured exercise.Researchers at the University of Copenhagen studied people stopping GLP-1 medication after a year of use.Those who followed a structured program of resistance and cardio training regained almost no weight — averaging about five pounds over a year.Those returning to sedentary habits regained most of their weight.Exercise appeared to restore the body's natural GLP-1-like hormone production.This is not about willpower.It's biological rehabilitation.Closing — A Changing LandscapeThese three approaches show that weight regain after GLP-1 is not inevitable.The science is evolving quickly.I'll continue tracking new developments and sharing updates here.Thanks for listeninGary Pepper, M.D., an associate professor at a prominent medical school and endocrinologist with 40 years of experience, brings clarity to numerous topics within the field of metabolic health. His view points are unhindered by corporate interests, unlike many other current "thought leaders" in medicine. Dr. Pepper, a dedicated educator, established his homebase website www.metabolism.com in 1996 and has blogged on important topics since then. Not one to be left behind by technology he began podcasting in 2020 with the onset of the pandemic and continues publishing vlogs on YouTube at his channel metabolism123. So whatever your choice in media, you will be gaining fresh insights by tuning in to his opinionated shows or reading his blogs on critical health topics.

BuB warnt euch! Vor allen Abzocken und Abofallen! Und vor schlechter Kleidung. Ob die 'Übergangsjacke Model Emilio' wirklich sein muss? Ob jeder eine Showhose haben sollte? Und ob zehnmal das gleiche Paar Schuhe haben auch Fashion ist? All diese Fragen beantworten die zwei Modeschöpfer Basti und Özcan - aka Sprühwurst und Baklava. Ihr kriegt diesmal eine Folge, die eine Bandbreite hat von Ozempic bis Süßigkeiten Ranking. Wohl bekomm's! Dieser Podcast wird vermarktet von Julep Media: sales@julep.de +++ Weitere Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/bratwurstundbaklava +++

Watch The X22 Report On Video No videos found (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:17532056201798502,size:[0, 0],id:"ld-9437-3289"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="https://cdn2.decide.dev/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");pt> Click On Picture To See Larger Picture The Fake News lost the narrative on the climate hoax. Trump bringing back the fishing industry in Maine. Everything is being reverse, jobs are coming back. Trump is moving the pieces on the board and preparing the country to move back to sound money and the is using the market as a weapon. The [DS] cannot keep the country divided anymore. The people are awake and they are seeing the true enemy through the fog. Trump is pushing everything to win the Midterms. We are watching the final countdown. Trump is exposing the system and the election cheating system to force the RINOS to pass the save act. Once this is done it is game over.   Economy https://twitter.com/ChrisMartzWX/status/2020341736896360591?s=20 (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:18510697282300316,size:[0, 0],id:"ld-8599-9832"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="https://cdn2.decide.dev/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");   foolishly reinstated them. Since Day One, I have taken historic action to END these disastrous policies and, today, I signed a Presidential Proclamation to UNLEASH Commercial Fishing in the Atlantic Ocean, advancing the America First Fishing Policy! I am restoring nearly 5,000 square miles of Fishing access off the Coast of New England, which will revitalize our Fishing Industry, and STRENGTHEN our Booming Economy. Congratulations to all of our Great Fishermen. Please remember I did this for you, against strong Democrat opposition, and VOTE REPUBLICAN IN THE MIDTERMS! PRESIDENT DONALD J. TRUMP  https://twitter.com/unusual_whales/status/2020181009124192563?s=20   https://twitter.com/Bobby1_x/status/2020284867708350837?s=20  house: 614 oz gold Now: 82 oz 1971 Car: 86 oz gold Now: 9 oz 1971 Harvard: 63 oz gold Now: 11 oz 1971 Gas: 1 oz gold = 113 gallons Now: 1 oz gold = 1736 gallons If you saved in dollars your value inflated away to almost nothing But if you saved in gold you INCREASED your real world purchasing power MASSIVELY You didn’t see inflation, you saw deflation And you never even had to do so much as sell as stock or learn about bonds and interest rates All you had to do was save in gold Gold is and always will be the ultimate store of value https://twitter.com/KobeissiLetter/status/2020229075487322323?s=20  By comparison, the 2020 high and 2012 peak were 40.9 million and 43.4 million, respectively. Meanwhile, ETFs of gold and other precious metals attracted +$4.39 billion in inflows in January, posting their 8th consecutive monthly intake. Furthermore, investors have invested a net +$3.62 billion in gold miner ETFs, the most since at least 2009. Demand for gold investments remains robust. https://twitter.com/MrPool_QQ/status/2020219515615793465?s=20  Reserve nominee if he doesn’t lower rates. “It was a joke.” No. It was a WARNING. The Fed’s days are numbered. MOVE 3: Pentagon CUT ALL TIES with Harvard. Military training. Fellowships. Programs. ALL GONE. The Ivy League pipeline to power is DEAD. MOVE 4: Launched TrumpRx. 43 medications. Ozempic included. Big Pharma’s monopoly: BROKEN. They charged you $1,000. He’s giving it for $300. MOVE 5: DHS funding expires February 13th. 6 days from now. Controlled shutdown incoming. Why? Because you can’t RESTRUCTURE what’s still running. Connect the dots: Iran tariffs = END of petrodollar Fed threat = END of central banking control Harvard cut = END of Deep State recruitment TrumpRx = END of Big Pharma monopoly DHS shutdown = RESTRUCTURING of homeland security This isn’t chaos. This is a DEMOLITION. Piece by piece. System by system. Pillar by pillar. The old world is being dismantled in REAL TIME. And the new one is being built while you watch.  DARK TO LIGHT   Political/Rights https://twitter.com/ICEgov/status/2019804241343234265?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2019804241343234265%7Ctwgr%5Ea4849f0e923af3c8c6337a4af454066151ac3a71%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fsupposedly-autistic-womans-tale-being-abused-arrested-ice%2F   the location, continued to impede our officers, and found out the hard way. 18 U.S.C. § 111 criminalizes impeding or interfering with federal officers. Team Trump Catches Gavin Newsom in a HUGE Lie During Back-and-Forth as California Governor Releases Thousands of Violent Criminal Illegals Back into Society https://twitter.com/KristiNoem/status/2019831108511158481?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2019831108511158481%7Ctwgr%5Ed4914c3e3e7d1872b32b0c54f58216356aecffd0%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fteam-trump-catches-gavin-newsom-huge-lie-during%2F https://twitter.com/CAgovernor/status/2019876274798567749?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2019876274798567749%7Ctwgr%5Ed4914c3e3e7d1872b32b0c54f58216356aecffd0%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fteam-trump-catches-gavin-newsom-huge-lie-during%2F https://twitter.com/USAttyEssayli/status/2019883966355107911?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2019883966355107911%7Ctwgr%5Ed4914c3e3e7d1872b32b0c54f58216356aecffd0%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fteam-trump-catches-gavin-newsom-huge-lie-during%2F   The law in question is the California Values Act (SB 54), signed into law in 2017 by then-Governor Jerry Brown. The legislation bars state and local resources from being used to assist federal immigratio Source: thegatewaypundit.com https://twitter.com/liz_churchill10/status/2020347917962473789?s=20 https://twitter.com/elonmusk/status/2020451356562096282?s=20 https://twitter.com/KanekoaTheGreat/status/2020249786017095995?s=20   https://twitter.com/Kimberlyrja8/status/2019799463129133362?s=20  , Savannah stated, “[Nancy] is full of kindness and knowledge. Talk to her, and you'll see.” Many have noticed that the phrasing is nearly identical to the line from the famous thriller, when Sen. Ruth Martin addresses the kidnapper of her daughter, Catherine, saying, “Catherine is very gentle and kind. Talk to her, and you'll see.” https://twitter.com/IENouwen/status/2020088584964125145?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2020088584964125145%7Ctwgr%5E35d5b78a17a39c8933cea82db5535043ef4b09ff%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fwatch-savannah-guthrie-echoed-iconic-silence-lambs-line%2F TAKE A LISTEN   https://twitter.com/RyanSaavedra/status/2019972293032833214?s=20 https://twitter.com/drawandstrike/status/2020283785451806956?s=20   is coming. Remember immediately after that last tranche of documents were released, all of a sudden our international elite class of baby-farming, baby-eating kid fucking criminals were in an increasingly untenable position, where some of ’em had to resign from important positions, and others were being forced into exceedingly awkward explanations/apologies? Well how do you stop the train? How do you arrest the progress of the exposure of your baby-eating/kid fucking activities? Wouldn’t you try to come up with a way to do damage control where you make as VERY PROMINENT PUBLIC WARNING to the mainstream media: You do NOT really want to GO THERE and keep asking us awkward questions. BACK THE FUCK OFF. It could be YOUR mother next…TAKE THE HINT… Now… Who is she? Who is she pictured with? Where was the picture taken? Will Bill Clinton be asked on February 28 who she is and why he was with her on Epstein’s plane? Stay tuned for developments. https://twitter.com/ByronYork/status/2020107433612288444?s=20   BREAKING: Pam Bondi Announces Arrest of Key Suspect in the 2012 Benghazi Attack (VIDEO)  Attorney General Pam Bondi announced on Friday morning that the FBI arrested one of the key players behind the deadly terrorist attack against the US Consulate in Benghazi. Islamic terrorists attacked the US Consulate in Benghazi on September 11, 2012, eleven years after the attacks on the World Trade Center. As noted previously, the Libyan nightmare was the result of a war that President Obama and Hillary Clinton started.  They never should have started the war in Libya, never should have placed Americans there unprotected, and when the Americans in Benghazi were under attack on 9-11, 2012 they should have provided help.  Instead, four Americans died in Benghazi as was famously portrayed in the movie 13 Hours. For days after the attack on Benghazi, President Obama and Hillary Clinton blamed the attack in Benghazi on a made up story about a US citizen who incited protests in Benghazi from a YouTube video about Islam. They continued with the story as the caskets of the four dead Americans, including Ambassador Chris Stevens, were shipped back to the US. Barack Obama and Hillary Clinton left the Consulate to fend for itself and never sent military support to rescue the men trapped at the Consulate. Attorney General Pam Bondi: On September 11th, 2012, Americans watched horrified as our embassy in Bengasi came under a vicious terror attack. We lost four American lives that day: Ambassador Chris Stevens, Sean Smith with the State Department, and two CIA contractors, Glenn Dordy and Tyrone Woods. We have never forgotten those heroes, and we have never stopped seeking justice for that crime against our nation. In fact, from day one, Cash and Dan would sit in meetings and say, We're going to get them, and they did. Today, I'm proud to announce that the FBI has arrested one of the key participants behind the Bengasi attack. Zubar Albaqash landed at Andrews Air Force Base at 03: 00 AM this morning. He is in our custody. He was greeted by Director Director Patel and US attorney Jeanine Piero. Source: thegatewaypundit.com   DOGE Geopolitical https://twitter.com/GuntherEagleman/status/2020137645339226362?s=20   supposed to GUARANTEE freedom, not RESTRICT it!” Poland standing tall against Brussels' Big Brother nonsense. This is what real leadership looks like. No bowing to globalist overlords. Poland remains a STRONG ally of the USA and a fighter for liberty.   Illegal Migrants and Gang Members out of the United States. We discussed many other issues, including Investment and Trade between our two Countries. He loves the people of Honduras, and is focused on their Health, Well-being, Education, and Economic Prosperity. I look forward to welcoming President Asfura back to the United States. Tito: Congratulations on your Great Victory! PRESIDENT DONALD J. TRUMP War/Peace https://twitter.com/BuzzPatterson/status/2020388749834965399?s=20 https://twitter.com/Osint613/status/2020238386108543128?s=20 Security Alert: Land Border Crossings (February 5, 2026) Location:  Iran, countrywide Event:  Increased security measures, road closures, public transportation disruptions, and internet blockages are ongoing. The Government of Iran continues to restrict access to mobile, landline, and national internet networks. Airlines continue to limit or cancel flights to and from Iran. U.S. citizens should expect continued internet outages, plan alternative means of communication, and, if safe to do so, consider departing Iran by land to Armenia or Türkiye. Actions to Take: Leave Iran now. Have a plan for departing Iran that does not rely on U.S. government help. Flight cancellations and disruptions are possible with little warning. Check directly with your airlines for updates. If you cannot leave, find a secure location within your residence or another safe building. Have a supply of food, water, medications, and other essential items. Avoid demonstrations, keep a low profile, and stay aware of your surroundings. Monitor local media for breaking news. Be prepared to adjust your plans. Keep your phone charged and maintain communication with family and friends to inform them of your status. Enroll in the Smart Traveler Enrollment Program (STEP)  to receive the latest updates on security in Iran. If You Plan to Leave Iran:  U.S.-Iranian dual nationals must exit Iran on Iranian passports.  The Iranian government does not recognize dual nationality  and will treat U.S.-Iranian dual nationals solely as Iranian citizens. U.S. nationals are at significant risk of questioning, arrest, and detention in Iran. Showing a U.S. passport or demonstrating connections to the United States can be reason enough for Iranian authorities to detain someone.  U.S. citizens who do not have a valid U.S. passport in their possession should apply for one at the nearest U.S. embassy or consulate after departing Iran. The U.S. government cannot guarantee your safety if you choose to depart using the following options. You should leave only if you believe it is safe to do so. As of Thursday, February 5:   Source:    Medical/False Flags China Bombshell: Patel says Biden-era FBI ‘buried' truth about CCP's ties to biolab on US soil  FBI Director Kash Patel says his agency has resumed an aggressive counterintelligence offensive against China and its Communist Party (CCP) that had been sidelined during the Biden presidency but is concerned the prior administration may have “buried” the truth about dangerous biolabs on U.S. soil tied to Beijing. The FBI boss said the renewed efforts have already resulted in a 40% increase in Chinese espionage arrests in the first year of the second Trump administration. Source: justthenews.com  [DS] Agenda ICE Humilates Far-Left Boston Mayor Michelle Wu in EPIC Fashion After She Signs Executive Order Barring Agency from Conducting “Unconstitutional and Violent” Operations ICE agents delivered a humiliating and richly deserved blow to Boston Mayor Michelle Wu's ego on Friday, one day after she tried to hamstring them for doing their jobs. As WHDH reported, Wu signed an “An Executive Order To Protect Bostonians From Unconstitutional and Violent Federal Operations.” Specifically, the order bans federal officials, including ICE, from using city property for immigration enforcement operations. Wu's office says the order is designed to “protect residents from illegal federal overreach, prioritizing de-escalation, and reaffirms that Boston will hold anyone accountable who commits violence, property damage, or any criminal conduct in the City, including federal officials.” Source: thegatewaypundit.com https://twitter.com/libsoftiktok/status/2020487139377443327?s=20 https://twitter.com/WallStreetApes/status/2019900883082031120?s=20   https://twitter.com/Badhombre/status/2019488291263823960?s=20    “People for the American Way” and Brian Tyler Cohen's “Chorus.” People for the American Way receives most of its funding from George Soros' Open Society Foundations. Brian Tyler Cohen @briantylercohen was recently exposed in a scandal for receiving dark money from the Sixteen Thirty Fund and paying up to $8,000 a month to influencers like Olivia Julianna, David Pakman, JoJo From Jerz, and Leigh “Politics Girl” McGowan to amplify coordinated content. The Sixteen Thirty Fund, managed by Arabella Advisors, receives its funding from three major sources: – Berger Action Fund (Swiss billionaire Hansjörg Wyss) – Open Society Policy Center (Hungarian Billionaire George Soros) – Democracy Fund Voice (French-born eBay founder Pierre Omidyar). Twelve people run the “HQ” account full-time. This is yet another coordinated propaganda campaign funded by leftist billionaires attempting to push their globalist agenda and sow division. Nothing organic or truly Gen-Z about it beyond the faces used to represent it. https://twitter.com/visegrad24/status/2020289816882024790?s=20 President Trump's Plan https://twitter.com/Rightanglenews/status/2020293934413680968?s=20 NBC CAUGHT IN ANOTHER LIE: VP Vance and Wife Were Not Booed at Olympics – It Was Quite the Opposite Vice President J.D. Vance, his with Usha and three children are representing the United States this week at the Winter Olympics.   J.D. was a hit at the Olympics venue.  On Friday night during the opening ceremonies NBC claimed the crowd was booing when J.D. Vance and his wife were pictured on the big screen. What disgusting people. Of course, this lie was quickly exposed by several fact-checkers online. Ovation Eddie 2 caught the media in their latest disgusting lie: https://twitter.com/EricLDaugh/status/2020155556158136778?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E2020155556158136778%7Ctwgr%5Ed35db378d07d7f30cba1d9449c0da87c52040e2a%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.thegatewaypundit.com%2F2026%2F02%2Fnbc-caught-another-lie-vp-vance-wife-were%2F   Remember: You can never trust a single word coming from the anti-Trump, Anti-American legacy media. Source: thegatewaypundit.com   https://twitter.com/MrAndyNgo/status/2020310461267202235?s=20   https://twitter.com/CynicalPublius/status/2020285717713453058?s=20   that out. Democrats Cry As Trump Makes It Easier to Fire Federal Workers The Trump administration is planning to make it easier to discipline—and potentially fire—career officials in senior positions across the government, a move that would affect roughly 50,000 federal workers. The U.S. Office of Personnel Management, which oversees the federal workforce, issued a final rule on Thursday that creates a category of worker for high-ranking career employees whose work focuses on executing the administration's policies. Workers who fall into that category would no longer be subject to rules that for decades have set a high bar for firing federal employees.  The Trump team, however, characterizes the move as one that gives the executive branch the ability to better shape the bureaucracy to help serve its agenda, instead of allowing it to clandestinely thwart it: The administration has been clear that the goal of the rule is to more easily fire workers they argue are hindering Trump policies — a nod to the president's claims of a “Deep State” within the federal government trying to undermine him. “This is not about people's views or ideas. This is about whether they are refusing to actually affect their duties on behalf of the American people consistent with the objectives of this administration,” said Scott Kupor, director of the Office of Personnel Management (OPM), which promulgated the rule.   Source: redstate.com https://twitter.com/drawandstrike/status/2020298873923567783?s=20   doesn’t agree with the 5th Circuit’s ruling. How in the world would you REINSTATE a policy where an illegal who successfully evaded detection at a port of entry has legal recourse to bond when those illegals detected at a port of entry do not? The 5th just rightfully found that NEITHER kind of illegal should have recourse to bond – whether they are detected at a port of entry or they successfully sneak into the country and are here for months/years before being caught. The fact this absurd situation persisted for decades shows you the system was rigged to allow human trafficking and to create a literal legal industry to facilitate it.      Trump can “legally” mass deport ALL illegals, whether they have committed a crime or not. “A federal appeals court ruled that Trump administration can lock up the vast majority of people it is seeking to deport without offering a chance for bond, even if they have no criminal records and have resided in the country for decades.        https://twitter.com/alexahenning/status/2020196173663867144?s=20 https://twitter.com/HansMahncke/status/2020253940374245522?s=20   https://twitter.com/DNIGabbard/status/2020227805976678574?s=20  control of the Whistleblower's complaint, so I obviously could not have “hidden” it in a safe. Biden-era IC Inspector General Tamara Johnson was in possession of and responsible for securing the complaint for months. – The first time I saw the whistleblower complaint was 2 weeks ago when I had to review it to provide guidance on how it should be securely shared with Congress. – As Vice Chair of the Senate Intelligence Committee, Senator Warner knows very well that whistleblower complaints that contain highly classified and compartmented intelligence—even if they contain baseless allegations like this one—must be secured in a safe, which the Biden-era Inspector General Tamara Johnson did and her successor, Inspector General Chris Fox, continued to do. After IC Inspector General Fox hand-delivered the complaint to the Gang of 8, the complaint was returned to a safe where it remains, consistent with any information of such sensitivity. – Either Senator Warner knows these facts and is intentionally lying to the American people, or he doesn't have a clue how these things work and is therefore not qualified to be in the U.S. Senate—and certainly not the Vice Chair of the Senate Intelligence Committee. Here is a detailed chronology of the situation: – June 2025, I became aware that a whistleblower made a complaint against me that after further investigation, neither Biden-era IC Inspector General Tamara Johnson nor current IC Inspector General Chris Fox found the complaint to be credible. – The complaint required special handling and storage in a safe because the complainant chose to include highly sensitive information within the complaint itself rather than referencing the sensitive reporting and leaving the complaint at a lower level of classification. – Security standards for complaints that include such sensitive intelligence required the Inspector General to keep the complaint and the intelligence referenced secured in a safe from the time the complaint was made, until now. – In June 2025 after Biden-era Inspector General Tamara Johnson completed her review of the complaint, no further oversight or investigative activity took place. – Biden-era Inspector General Johnson had communicated with me directly throughout the course of her investigation into this complaint, yet neither she nor anyone from her office informed me that the Whistleblower chose to send the complaint to Congress which would require me to issue security instructions. – When a complaint is not found to be credible, there is no timeline under the law for the provision of security guidance. The “21 day” requirement that Senator Warner alleges I did not comply with, only applies when a complaint is determined by the Inspector General to be both urgent AND apparently credible. That was NOT the case here. – I was made aware of the need to provide security guidance by IC Inspector General Chris Fox on December 4, 2025, which he detailed in his letter to Congress. – I took immediate action to provide the security guidance to the Intelligence Community Inspector General who then shared the complaint and referenced intelligence with relevant members of Congress last week. Senator Warner’s decision to spread lies and baseless accusations over the months for political gain, undermines our national security and is a disservice to the American people and the Intelligence Community. https://twitter.com/seanmdav/status/2020151219210137711?s=20   https://twitter.com/AlecLace/status/2019802427487027667?s=20 https://twitter.com/WallStreetMav/status/2020150184374681890?s=20 https://twitter.com/AlecLace/status/2019849309148311983?s=20 https://twitter.com/TheStormRedux/status/2019941561367191842?s=20 https://twitter.com/Rasmussen_Poll/status/2020183096667128211?s=20  2. ALL VOTERS MUST SHOW PROOF OF UNITED STATES CITIZENSHIP TO REGISTER FOR VOTING.   3. NO MAIL-IN BALLOTS (EXCEPT FOR ILLNESS, DISABILITY, MILITARY, OR TRAVEL!). https://twitter.com/WarClandestine/status/2020314452483342609?s=20     (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:13499335648425062,size:[0, 0],id:"ld-7164-1323"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="//cdn2.customads.co/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");

Comedian and Podcaster Adam Carolla joins Bill Maher for a blunt conversation that moves from Hollywood war stories to California's political dysfunction. They unpack the reality of entertainment careers—how early wins create false confidence and why setbacks are unavoidable. Carolla revisits his early breaks with Loveline and The Man Show, while Maher reflects on losing his father just before Politically Incorrect took off. The conversation then widens to identity politics and DEI backlash, overregulation and government bloat, discipline versus Ozempic shortcuts, and how Carolla's emotionally distant upbringing shaped his independence and worldview—before giving way to classic Club Random humor, from Pop-Tarts to Elvis and strip-club metaphors. Support our Advertisers: -Head to https://www.squarespace.com/CLUBRANDOM to save 10% off your first purchase of a website or domain using code CLUBRANDOM.  -Get 50% off your first box plus free breakfast for 1 year at https://www.factormeals.com/random50off -Protect your car with CarShield. Get 20% off at http://www.carshield.com with code RANDOM Subscribe to the Club Random YouTube channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/c/clubrandompodcast?sub_confirmation=1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Watch episodes ad-free – subscribe to Bill Maher's Substack: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://billmaher.substack.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Subscribe to the podcast for free wherever you listen: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/ClubRandom⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Buy Club Random Merch: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://clubrandom.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit https://podcastchoices.com/adchoices ABOUT CLUB RANDOM Bill Maher rewrites the rules of podcasting the way he did in television in this series of one on one, hour long conversations with a wide variety of unexpected guests in the undisclosed location called Club Random. There's a whole big world out there that isn't about politics and Bill and his guests—from Bill Burr and Jerry Seinfeld to Jordan Peterson, Quentin Tarantino and Neil DeGrasse Tyson—talk about all of it.  For advertising opportunities please email: PodcastPartnerships@Studio71us.com ABOUT BILL MAHER Bill Maher was the host of “Politically Incorrect” (Comedy Central, ABC) from 1993-2002, and for the last fourteen years on HBO's “Real Time,” Maher's combination of unflinching honesty and big laughs have garnered him 40 Emmy nominations. Maher won his first Emmy in 2014 as executive producer for the HBO series, “VICE.” In October of 2008, this same combination was on display in Maher's uproarious and unprecedented swipe at organized religion, “Religulous.” Maher has written five bestsellers: “True Story,” “Does Anybody Have a Problem with That? Politically Incorrect's Greatest Hits,” “When You Ride Alone, You Ride with Bin Laden,” “New Rules: Polite Musings from a Timid Observer,” and most recently, “The New New Rules: A Funny Look at How Everybody But Me Has Their Head Up Their Ass.” FOLLOW CLUB RANDOM https://www.clubrandom.com https://www.facebook.com/Club-Random-101776489118185 https://twitter.com/clubrandom_ https://www.instagram.com/clubrandompodcast https://www.tiktok.com/@clubrandompodcast FOLLOW BILL MAHER https://www.billmaher.com https://twitter.com/billmaher https://www.instagram.com/billmaher Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we sit down with Sarah Kennedy, Founder and CEO of Calocurb, to explore a radically different approach to appetite control rooted in real science, not willpower. With decades of leadership in nutrition and food science, Sarah breaks down how GLP-1s work, the downsides of chronic calorie restriction, and the key differences between synthetic drugs like semaglutide and natural GLP-1 stimulation. We dive into the history of bitters, digestion, and how Calocurb's patented ingredient Amarasate® supports appetite regulation through the gut–brain axis. Sarah also shares compelling clinical trial results, insights on coming off GLP-1 drugs, and why under-eating—especially for women—can backfire hormonally. It's a nuanced, empowering conversation about working with your biology to feel satisfied, nourished, and in control.Founder and CEO of Calocurb, Sarah Kennedy shepherded years of scientific research and clinical trials to bring a revolutionary product to market. A veterinarian by training, with more than 20 years' experience in dietary and animal nutrition, Sarah has held a number of CEO and senior executive positions in food and agriculture industries, at companies including Fonterra and Healtheries/Vitaco NZ.  In 2010, at MIT, Sarah completed a Sloan Fellowship Program in Global Leadership and Innovation and has spent decades leading in health, nutrition and consumer products with executive roles at many, many companies.Calocurb is a 100% natural appetite control supplement. Amarasate®, the patented active ingredient in Calocurb, was developed in New Zealand over 14 years and with $30m invested by Plant and Food Research, the largest NZ government-owned research institute.SHOW NOTES:0:40 Welcome to the show!2:39 About Sarah Kennedy3:54 Welcome her to the podcast!5:04 What is a GLP-1?7:27 Downside of calorie restriction8:52 Natural vs synthetic GLP-113:41 Coming off of GLP-1s14:56 Why it isn't just willpower18:07 History of bitters in the diet20:12 Stimulating digestion & appetite suppression23:22 Calocurb Study26:02 Semaglutide vs Calocurb29:45 Clinical trial results32:54 Calocurb & PMS34:10 Dosing Calocurb40:08 Our personal experiences43:37 Importance of protein intake46:41 Females that are under-eating54:52 Where to find Sarah & Calocurb55:30 Her final piece of advice57:21 Thanks for tuning in!RESOURCES:Website: www.Calocurb.com - Discount code: BIOHACKERBABESIG: CalocurbFacebook: CalocurbGLOBALSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Słuchasz Karolina Sobańska Podcast. W tym programie rozmawiamy o dobrym świadomym życiu, śledzimy trendy i dyskutujemy o tym co dla nas ważne. Partnerem odcinka jest Olini [reklama]https://k.olini.pl/KARO10/kategoria/olejeTrendy 2026: wellnessmotywy przewodnie: social wellness / wellness travel / peptydy + wellness anxiety trendy 2023wellness z Los Angeles (2024)trendy 2025trendy 2026:sleep / health measurement anxiety GLP-1peptydykomórki macierzyste kroplówkiżelatynabłonniksoda białkowaodwrócona dietawyrzeźbione ręcepanele ledowemenopauzaroboty masażyściBądź na bieżąco :) www.instagram.com/KarolinaSobanska⁠⁠⁠⁠www.karolinasobanska.com⁠⁠ Współpraca: karolina@pasnormal.group00:00 intro08:12 sleep / health measurement anxiety14:50 GLP-119:15 suplementy23:35 błonnik25:36 woda białkowa26:52 odwrócona dieta29:35 panele ledowe31:13 menopauza32:11 roboty masażyści33:17 podsumowanie

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

Legal issues hits Hims & Hers (HIMS). Novo Nordisk (NVO) filed a lawsuit against the company over allegedly selling unapproved Wegovy and Ozempic weight loss drugs. Marley Kayden takes investors through the details and the stark sell-off shedding weight off HIMS stock. Prosper Trading Academy's Charles Moon takes investors through an example options trade navigating the current selling action. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

We welcome back Dr. Jake Deutsch, founder and director of Oakwood Precision Medicine and our go-to longevity expert, to break down what peptides actually are, how they work, and where science ends, and speculation begins.Peptides and regenerative medicine are reshaping how we think about health, aging, aesthetics, and longevity, but as this space rapidly evolves, it is also filled with hype, confusion, and real risks when used without proper understanding or oversight.Together, we discuss: • What peptides are and how they are regulated • The role of GLP-1 peptides in weight loss, metabolic health, and longevity • The difference between strategic use and misuse, including concerns around muscle loss, bone health, and so-called “Ozempic face” • The most talked-about peptides in longevity and aesthetics and how they are administered • The risks of stacking and cycling and what proper monitoring should really look like • Why the conversation is shifting from lifespan alone to vitality, quality of life, and optimized aging • How beauty from the inside out is changing aesthetic medicine, from lifestyle and supplements to advanced regenerative toolsThis is a grounded, science-forward conversation about using powerful tools responsibly, safely, and with intention for long-term health.

How did weight-loss drugs move from medical niche to global phenomenon Aimee Donnellan, Reuters columnist and author of Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity, joins Karl Henry on this week's episode of The Real Health podcast. This episode of The Indo Daily is brought to you by our sister podcast, Real Health with Karl Henry See omnystudio.com/listener for privacy information.

In this bonus episode of The Alan Sanders Show, dive into President Trump's bold move with the launch of TrumpRx.gov, delivering massive discounts on high-cost prescription drugs like Ozempic and Wegovy through Most-Favored-Nation pricing for huge savings on essential medications. Plus, the dismantling of wasteful DEI programs across the federal government to restore merit-based opportunity get the green light from the 4th Circuit Court of Appeal. And breaking immigration enforcement: the 5th Circuit Court of Appeals says ICE can keep any illegal in permanent detention until their scheduled immigration hearing, without being released. Catch the latest on these America First wins! Bonus Ep. 08. Please take a moment to rate and review the show and then share the episode on social media. You can find me on Facebook, X, Instagram, GETTR, TRUTH Social, TikTok, YouTube and Rumble by searching for The Alan Sanders Show. And, consider becoming a sponsor of the show by visiting my Patreon page!

In this episode, Ben Azadi reveals the hidden risks of Ozempic and GLP-1 weight loss drugs that are rarely discussed. While these medications may lead to quick weight loss, Ben explains why much of that loss comes from muscle, not fat, and how this can slow metabolism and increase long-term fat regain. You'll learn the critical difference between weight loss and true fat loss, why muscle is essential for metabolic health, and how appetite suppression can quietly sabotage hormones, energy, and recovery. Ben breaks down the four real drivers of weight gain: insulin resistance, chronic inflammation, gut dysfunction, and nutrient depletion. This episode also covers why Ozempic is not a moral or willpower issue, but a metabolic signaling problem, and why obesity is a hormonal condition, not a personal failure. Ben shares a science-backed alternative approach focused on lowering insulin naturally, preserving muscle through resistance training, and healing the gut to restore hunger signals. If you or someone you love is using Ozempic or considering it, this episode offers clarity, compassion, and a sustainable path to real metabolic health without dependency on drugs.

They discuss various cosmetic procedures, the effectiveness of drugs like Ozempic and ZepBound, and address issues such as sagging skin caused by these medications, along with solutions.

United States Attorney General Pam Bondi discusses the custody of a key participant in the 2012 Benghazi attack, which killed four Americans. The family of Savannah Guthrie's mother appeals to the public for information as the emotional toll of her disappearance grows. Authorities have provided updates on the search, and Mark offers a breakdown of the situation. Mark takes your calls!  Mark interviews plastic surgeon Dr. Arthur Perry. They discuss various cosmetic procedures, the effectiveness of drugs like Ozempic and ZepBound, and address issues such as sagging skin caused by these medications, along with solutions.

They discuss various cosmetic procedures, the effectiveness of drugs like Ozempic and ZepBound, and address issues such as sagging skin caused by these medications, along with solutions.See omnystudio.com/listener for privacy information.

United States Attorney General Pam Bondi discusses the custody of a key participant in the 2012 Benghazi attack, which killed four Americans. The family of Savannah Guthrie's mother appeals to the public for information as the emotional toll of her disappearance grows. Authorities have provided updates on the search, and Mark offers a breakdown of the situation. Mark interviews plastic surgeon Dr. Arthur Perry. They discuss various cosmetic procedures, the effectiveness of drugs like Ozempic and ZepBound, and address issues such as sagging skin caused by these medications, along with solutions. Did Senator Elizabeth Warren give Treasury Secretary Scott Bessent a supportive gesture during recent testimony about the nation's financial health? Minority Leader Chuck Schumer continues to oppose voter ID requirements, arguing that they would disenfranchise immigrants and likening the policy to a return to similar Jim Crow laws from the 1900's. Mark interviews author Mark Malkoff. Their conversation centers on Johnny Carson's legacy of making stars of his guests and on speculation about the future of late-night television, with Malkoff predicting its potential end depending on changes in the broadcasting landscape. See omnystudio.com/listener for privacy information.

United States Attorney General Pam Bondi discusses the custody of a key participant in the 2012 Benghazi attack, which killed four Americans. The family of Savannah Guthrie's mother appeals to the public for information as the emotional toll of her disappearance grows. Authorities have provided updates on the search, and Mark offers a breakdown of the situation. Mark takes your calls!  Mark interviews plastic surgeon Dr. Arthur Perry. They discuss various cosmetic procedures, the effectiveness of drugs like Ozempic and ZepBound, and address issues such as sagging skin caused by these medications, along with solutions. See omnystudio.com/listener for privacy information.

Chris Franjola is here and we do not hold back! Where is Savannah Guthrie's missing mom? Out of curiosity, I saw the Melania Trump movie and I give my honest review. More is coming out of the Epstein files. Deepak Chopra is all over it. Will anyone lose their job or at least their podcast over it? Will people switch over to the alternative Super Bowl show? Jelly Roll claims to not know anything but where to find a good dentist. Don't give your kid your Ozempic and funny grand babies are being born! So juicy so funny! Enjoy! -Use code JUICYSCOOP at ⁠https://jonesroadbeauty.com⁠ to get a Free Shimmer Face Oil with your first purchase! #JonesRoadBeauty #ad #sponsored  -Take proactive care of your health and head to ⁠https://OPositiv.com/JUICYSCOOP⁠ or enter JUICYSCOOP at checkout for 25% off your first purchase.  -Go to ⁠⁠⁠⁠https://RO.CO/JUICYSCOOP⁠⁠⁠⁠ to see if you're eligible for the new GLP-1 pill on Ro -Go to ⁠⁠⁠⁠⁠https://quince.com/juicy⁠⁠⁠⁠⁠ for free shipping on your order and 365-day returns. Now available in Canada, too. -Sign up for your one-dollar-per-month trial and start selling today at ⁠⁠⁠⁠https://shopify.com/juicy⁠⁠⁠⁠  Subscribe to my new show Juicy Crimes!: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/juicycrimes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Stand Up Tickets and info: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://heathermcdonald.net⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Subscribe to Juicy Scoop with Heather McDonald and get extra juice on Patreon: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/JuicyScoopPod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/juicyscoop ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Watch the Juicy Scoop On YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@JuicyScoop⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Shop Juicy Scoop Merch: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://juicyscoopshop.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Me on Social Media: Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/heathermcdonald⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@heathermcdonald⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@HeatherMcDonaldOfficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices